Search Results

There are 56650 results for: content related to: Proton pump inhibitor omeprazole use is associated with low bone mineral density in maintenance haemodialysis patients

  1. You have free access to this content
    Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 11, June 2015, Pages: 1162–1174, S. E. Attwood, C. Ell, J. P. Galmiche, R. Fiocca, J. G. Hatlebakk, B. Hasselgren, G. Långström, M. Jahreskog, S. Eklund, T. Lind and L. Lundell

    Version of Record online : 10 APR 2015, DOI: 10.1111/apt.13194

  2. You have free access to this content
    Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 6, June 2000, Pages: 651–668, Laine, Ahnen, Mcclain, Solcia and Walsh

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00768.x

  3. Pharmacogenetics of the Proton Pump Inhibitors: A Systematic Review

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 23, Issue 4, April 2003, Pages: 460–471, Elaine Chong and Mary H. H. Ensom

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.23.4.460.32128

  4. You have free access to this content
    PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis

    Neurogastroenterology & Motility

    Volume 24, Issue 8, August 2012, Pages: 747–e350, P. W. Weijenborg, F. Cremonini, A. J. P. M. Smout and A. J. Bredenoord

    Version of Record online : 6 FEB 2012, DOI: 10.1111/j.1365-2982.2012.01888.x

  5. You have full text access to this OnlineOpen article
    The Effect of Orally Administered Ranitidine and Once-Daily or Twice-Daily Orally Administered Omeprazole on Intragastric pH in Cats

    Journal of Veterinary Internal Medicine

    Volume 29, Issue 3, May/June 2015, Pages: 840–846, S. Šutalo, M. Ruetten, S. Hartnack, C.E. Reusch and P. H. Kook

    Version of Record online : 13 MAY 2015, DOI: 10.1111/jvim.12580

  6. Omeprazole as a CYP2C19 Marker in Chinese Subjects: Assessment of Its Gene-Dose Effect and Intrasubject Variability

    The Journal of Clinical Pharmacology

    Volume 44, Issue 6, June 2004, Pages: 582–589, Dr. Ophelia Q. P. Yin, Dr. Brian Tomlinson, Dr. Albert H. L. Chow, Dr. Mary M. Y. Waye and Dr. Moses S. S. Chow

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004265702

  7. Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 3, September 1999, Pages: 265–274, Takahisa Furuta, Kyoichi Ohashi, Kaoru Kobayashi, Izumi Iida, Hideo Yoshida, Naohito Shirai, Misako Takashima, Kazuhiro Kosuge, Hiroyuki Hanai, Kan Chiba, Takashi Ishizaki and Eizo Kaneko

    Version of Record online : 26 SEP 1999, DOI: 10.1016/S0009-9236(99)70034-2

  8. You have free access to this content
    Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: A meta-analysis

    Journal of Gastroenterology and Hepatology

    Volume 20, Issue 1, January 2005, Pages: 11–25, MOHAMMED S KHUROO, MEHNAAZ S KHUROO, KARIM LC FARAHAT and INGVAR E KAGEVI

    Version of Record online : 21 MAY 2009, DOI: 10.1111/j.1440-1746.2004.03441.x

  9. Effect of Low-Dose Omeprazole (20 mg Daily) on the Pharmacokinetics of Multiple-Dose Atazanavir With Ritonavir in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 51, Issue 3, March 2011, Pages: 368–377, Li Zhu, Anna Persson, Lisa Mahnke, Timothy Eley, Tong Li, Xiaohui Xu, Sangeeta Agarwala, Jeffrey Dragone and Richard Bertz

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010367651

  10. Ethnic and genetic determinants of omeprazole disposition and effect

    Clinical Pharmacology & Therapeutics

    Volume 60, Issue 2, August 1996, Pages: 157–167, Yoseph Caraco, Per-Olaf Lagerstrom and Alastair J.J. Wood

    Version of Record online : 23 AUG 1996, DOI: 10.1016/S0009-9236(96)90131-9

  11. CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans

    Clinical Pharmacology & Therapeutics

    Volume 65, Issue 5, May 1999, Pages: 552–561, Takahisa Furuta, Kyoichi Ohashi, Kazuhiro Kosuge, Xue-Jun Zhao, Misako Takashima, Masahiko Kimura, Masahiko Nishimoto, Hiroyuki Hanai, Eizo Kaneko and Takashi Ishizaki

    Version of Record online : 13 MAY 1999, DOI: 10.1016/S0009-9236(99)70075-5

  12. Clopidogrel Inhibits CYP2C19-Dependent Hydroxylation of Omeprazole Related to CYP2C19 Genetic Polymorphisms

    The Journal of Clinical Pharmacology

    Volume 49, Issue 5, May 2009, Pages: 574–581, Dr B. L. Chen, Dr Y. Chen, Dr J. H. Tu, Dr Y. L. Li, Dr W. Zhang, Dr Q. Li, Dr L. Fan, Dr Z. R. Tan, Dr D. L. Hu, Dr D. Wang, Dr L. S. Wang, Dr D. S. OuYang and Dr H. H. Zhou

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009333016

  13. Pharmacokinetics of omeprazole in rats with water deprivation for 72 hours

    Biopharmaceutics & Drug Disposition

    Volume 27, Issue 8, November 2006, Pages: 361–370, Dae Y. Lee, Hyun S. Shin, Inchul Lee and Myung G. Lee

    Version of Record online : 8 AUG 2006, DOI: 10.1002/bdd.516

  14. Omeprazole Disposition in Children following Single-Dose Administration

    The Journal of Clinical Pharmacology

    Volume 43, Issue 8, August 2003, Pages: 840–848, Dr. Gregory L. Kearns, Dr. Tommy Andersson, Dr. Laura P. James, Dr. Andrea Gaedigk, Ms. Rebecca A. Kraynak, Dr. Susan M. Abdel-Rahman, Dr. Krishnaswami Ramabadran, Dr. John N. van den Anker and Pediatric Pharmacology Research Unit Network

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003256122

  15. You have full text access to this OnlineOpen article
    Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 6, September 2015, Pages: 649–663, L. Lundell, M. Vieth, F. Gibson, P. Nagy and P. J. Kahrilas

    Version of Record online : 16 JUL 2015, DOI: 10.1111/apt.13324

  16. You have free access to this content
    Clinical and fiscal impact of lansoprazole intolerance in veterans with gastro-oesophageal reflux disease

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 4, April 2000, Pages: 397–406, Gerson, Hatton, Ryono, Jones, Pulliam, Sampliner, Triadafilopoulos and Fass

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00726.x

  17. Induction of CYP2C19 and CYP3A Activity Following Repeated Administration of Efavirenz in Healthy Volunteers

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 3, March 2012, Pages: 475–482, V Michaud, E Ogburn, N Thong, A O Aregbe, T C Quigg, D A Flockhart and Z Desta

    Version of Record online : 8 FEB 2012, DOI: 10.1038/clpt.2011.249

  18. You have free access to this content
    Oral pharmacokinetics of omeprazole and lansoprazole after single and repeated doses as intact capsules or as suspensions in sodium bicarbonate

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 7, July 2000, Pages: 887–892, Sharma, Peyton, Spears, Raufman and Howden

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00794.x

  19. Omeprazole: The first proton pump inhibitor

    Medicinal Research Reviews

    Volume 10, Issue 1, January/March 1990, Pages: 1–54, Per Lindberg, Arne Brändström, Björn Wallmark, Hillevi Mattsson, Leif Rikner and Kurt-Jürgen Hoffmann

    Version of Record online : 18 SEP 2006, DOI: 10.1002/med.2610100102

  20. You have free access to this content
    Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 8, August 2000, Pages: 963–978, C. A. M. Stedman and M. L. Barclay

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00788.x